Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
5.520
-0.250
(-4.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 18, 2025
Add to My Watchlist
All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock![]() ![]()
Recursion Announces Plans to Open New Office in London
March 11, 2024
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024
Via GlobeNewswire
![]() ![]()
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via Talk Markets
Topics
Artificial Intelligence
![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|